{"id":75716,"date":"2026-04-23T13:01:39","date_gmt":"2026-04-23T07:31:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=75716"},"modified":"2026-04-23T13:01:41","modified_gmt":"2026-04-23T07:31:41","slug":"granules-india-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/","title":{"rendered":"Granules India Share Price Target 2026 \u2014 Analyst Forecast, Catalysts and Key Risks"},"content":{"rendered":"<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India<\/a> share price target 2026<\/strong> stands at <strong>Rs 587-687<\/strong> as per analyst consensus \u2014 implying <strong>21-41% upside<\/strong> from the current CMP of Rs 487. Investors tracking the <strong>Granules India share price target 2026<\/strong> need to understand the complete picture \u2014 the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Granules India (GRANULES) achieves or misses this 12-month target. This article covers every dimension of the <strong>Granules India share price target 2026<\/strong> thesis \u2014 catalysts, risks, scenarios, analyst ratings, and key levels \u2014 updated April 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free SEBI-registered Research on Granules India on Univest.<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Granules_India_Share_Price_Overview_%E2%80%94_April_2026\" title=\"Granules India Share Price Overview \u2014 April 2026\">Granules India Share Price Overview \u2014 April 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#What_Is_Granules_India\" title=\"What Is Granules India?\">What Is Granules India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Budget_2026-27_Impact_on_Pharma\" title=\"Budget 2026-27 Impact on Pharma\">Budget 2026-27 Impact on Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Granules_India_share_price_target_2026_%E2%80%94_Short_12-Month_and_Long-Term_Horizons\" title=\"Granules India share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons\">Granules India share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#5_Growth_Catalysts_Supporting_the_Granules_India_share_price_target_2026\" title=\"5 Growth Catalysts Supporting the Granules India share price target 2026\">5 Growth Catalysts Supporting the Granules India share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#1_India_Pharma_Sector_%E2%80%94_Structural_Growth_Tailwind\" title=\"1. India Pharma Sector \u2014 Structural Growth Tailwind\">1. India Pharma Sector \u2014 Structural Growth Tailwind<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#2_FY27_Earnings_Recovery_%E2%80%94_Primary_Re-Rating_Catalyst\" title=\"2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst\">2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#3_Competitive_Moat_%E2%80%94_Defensible_Market_Position_Built_Over_Decades\" title=\"3. Competitive Moat \u2014 Defensible Market Position Built Over Decades\">3. Competitive Moat \u2014 Defensible Market Position Built Over Decades<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#4_RBI_Rate_Cut_Cycle_%E2%80%94_Reducing_Cost_of_Capital\" title=\"4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital\">4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\" title=\"5. Budget 2026-27 Policy Alignment and Government Capex Support\">5. Budget 2026-27 Policy Alignment and Government Capex Support<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#5_Risks_That_Could_Impact_the_Granules_India_share_price_target_2026\" title=\"5 Risks That Could Impact the Granules India share price target 2026\">5 Risks That Could Impact the Granules India share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#1_US_Tariff_and_Global_Macro_Headwinds\" title=\"1. US Tariff and Global Macro Headwinds\">1. US Tariff and Global Macro Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#2_Valuation_at_22x_Requires_Consistent_Execution\" title=\"2. Valuation at 22x Requires Consistent Execution\">2. Valuation at 22x Requires Consistent Execution<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#3_Competition_Intensifying_in_Pharma\" title=\"3. Competition Intensifying in Pharma\">3. Competition Intensifying in Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#4_Input_Cost_and_Supply_Chain_Volatility\" title=\"4. Input Cost and Supply Chain Volatility\">4. Input Cost and Supply Chain Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#5_FII_Selling_Risk_%E2%80%94_148_Institutional_Holding\" title=\"5. FII Selling Risk \u2014 14.8% Institutional Holding\">5. FII Selling Risk \u2014 14.8% Institutional Holding<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Granules_India_Bull_Case_vs_Bear_Case_%E2%80%94_Granules_India_share_price_target_2026\" title=\"Granules India Bull Case vs Bear Case \u2014 Granules India share price target 2026\">Granules India Bull Case vs Bear Case \u2014 Granules India share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Granules_India_Share_Price_Reference_Table\" title=\"Granules India Share Price Reference Table\">Granules India Share Price Reference Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Analyst_Ratings_and_Granules_India_share_price_target_2026\" title=\"Analyst Ratings and Granules India share price target 2026\">Analyst Ratings and Granules India share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#How_to_Invest_in_Granules_India_%E2%80%94_5_Steps\" title=\"How to Invest in Granules India \u2014 5 Steps\">How to Invest in Granules India \u2014 5 Steps<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Step_1_Research_on_the_Univest_Screener\" title=\"Step 1: Research on the Univest Screener\">Step 1: Research on the Univest Screener<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Step_2_Identify_Entry_Level\" title=\"Step 2: Identify Entry Level\">Step 2: Identify Entry Level<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Step_3_Monitor_Q4_FY26_Results\" title=\"Step 3: Monitor Q4 FY26 Results\">Step 3: Monitor Q4 FY26 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Step_4_Position_Sizing\" title=\"Step 4: Position Sizing\">Step 4: Position Sizing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Step_5_Track_on_the_Univest_App\" title=\"Step 5: Track on the Univest App\">Step 5: Track on the Univest App<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Conclusion_%E2%80%94_Granules_India_share_price_target_2026\" title=\"Conclusion \u2014 Granules India share price target 2026\">Conclusion \u2014 Granules India share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Frequently_Asked_Questions_%E2%80%94_Granules_India_share_price_target_2026\" title=\"Frequently Asked Questions \u2014 Granules India share price target 2026\">Frequently Asked Questions \u2014 Granules India share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_What_is_Granules_India_share_price_target_for_2026\" title=\"Q: What is Granules India share price target for 2026?\">Q: What is Granules India share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_Is_Granules_India_a_good_buy_at_Rs_487\" title=\"Q: Is Granules India a good buy at Rs 487?\">Q: Is Granules India a good buy at Rs 487?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_What_is_Granules_India_52-week_high_and_low\" title=\"Q: What is Granules India 52-week high and low?\">Q: What is Granules India 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_What_sector_is_Granules_India_GRANULES_in\" title=\"Q: What sector is Granules India (GRANULES) in?\">Q: What sector is Granules India (GRANULES) in?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_What_are_the_main_risks_for_the_Granules_India_share_price_target_2026_thesis\" title=\"Q: What are the main risks for the Granules India share price target 2026 thesis?\">Q: What are the main risks for the Granules India share price target 2026 thesis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_What_is_Granules_Indias_market_cap\" title=\"Q: What is Granules India&#8217;s market cap?\">Q: What is Granules India&#8217;s market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_What_is_Granules_India_dividend_for_FY26\" title=\"Q: What is Granules India dividend for FY26?\">Q: What is Granules India dividend for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Q_How_to_buy_Granules_India_shares\" title=\"Q: How to buy Granules India shares?\">Q: How to buy Granules India shares?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/univest.in\/blogs-2\/granules-india-share-price-target-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Granules_India_Share_Price_Overview_%E2%80%94_April_2026\"><\/span><strong>Granules India Share Price Overview \u2014 April 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>Company<\/td>\n<td>Granules India<\/td>\n<\/tr>\n<tr>\n<td>NSE Symbol<\/td>\n<td>GRANULES<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharma \/ API Finished Dosage Form \/ US Export<\/td>\n<\/tr>\n<tr>\n<td>CMP April 2026<\/td>\n<td><strong>Rs 487<\/strong><\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 727<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 387<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 11,800 Cr<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>22x<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Rs 3<\/td>\n<\/tr>\n<tr>\n<td>Promoter Holding<\/td>\n<td>42.2%<\/td>\n<\/tr>\n<tr>\n<td>FII Holding<\/td>\n<td>14.8%<\/td>\n<\/tr>\n<tr>\n<td>12M Analyst Target<\/td>\n<td><strong>Rs 587-687<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Upside from CMP<\/td>\n<td><strong>21-41%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data from NSE\/BSE and publicly available research. April 2026. Verify before investing.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Track live Granules India price, FII\/DII flows and analyst targets on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Granules_India\"><\/span><strong>What Is Granules India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get Free Analyst Research on Granules India \u2014 Tap Here.<\/strong><\/a><\/p>\n<p>Granules India (NSE: GRANULES) manufactures bulk APIs and FDF (Finished Dosage Forms) \u2014 paracetamol, metformin, ibuprofen for US and European markets. FY26 revenue Rs 4,200 crore recovering post FY25 FDA headwinds. EBITDA margin expanding from 18% to 21%+.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Budget_2026-27_Impact_on_Pharma\"><\/span><strong>Budget 2026-27 Impact on Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Budget 2026-27&#8217;s API PLI supports Granules&#8217; bulk drug scale-up. US market demand recovery for OTC molecules benefits core product basket.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Granules_India_share_price_target_2026_%E2%80%94_Short_12-Month_and_Long-Term_Horizons\"><\/span><strong>Granules India share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Horizon<\/th>\n<th>Target<\/th>\n<th>Key Assumption<\/th>\n<\/tr>\n<tr>\n<td>Short-Term 3-6 Months<\/td>\n<td>Rs 587<\/td>\n<td>Q4 FY26 results beat and technical recovery<\/td>\n<\/tr>\n<tr>\n<td>12-Month Consensus<\/td>\n<td><strong>Rs 587-687<\/strong><\/td>\n<td>FY27 earnings delivery and macro normalisation<\/td>\n<\/tr>\n<tr>\n<td>Long-Term FY27-28<\/td>\n<td>20-30% above 12M<\/td>\n<td>Full earnings recovery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 387 zone<\/td>\n<td>FY27 miss and extended FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Granules India with sector peers live on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Growth_Catalysts_Supporting_the_Granules_India_share_price_target_2026\"><\/span><strong>5 Growth Catalysts Supporting the Granules India share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_India_Pharma_Sector_%E2%80%94_Structural_Growth_Tailwind\"><\/span><strong>1. India Pharma Sector \u2014 Structural Growth Tailwind<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s Pharma sector is expanding at 12-18% annually \u2014 driven by rising incomes, urbanisation, government policy, and the India structural growth story. Granules India&#8217;s market position within this sector creates compounding runway that underpins the <strong>Granules India share price target 2026<\/strong> consensus of Rs 587-687. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_FY27_Earnings_Recovery_%E2%80%94_Primary_Re-Rating_Catalyst\"><\/span><strong>2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Granules India to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the <strong>Granules India share price target 2026<\/strong> consensus of Rs 587-687. Track Q4 results live on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competitive_Moat_%E2%80%94_Defensible_Market_Position_Built_Over_Decades\"><\/span><strong>3. Competitive Moat \u2014 Defensible Market Position Built Over Decades<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Granules India holds a structural competitive moat in its Pharma segment \u2014 brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles \u2014 the structural argument for the premium valuation embedded in the <strong>Granules India share price target 2026<\/strong> of Rs 587-687.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_RBI_Rate_Cut_Cycle_%E2%80%94_Reducing_Cost_of_Capital\"><\/span><strong>4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle commenced in 2026 reduces Granules India&#8217;s borrowing costs and stimulates end-customer demand for Pharma products. Lower interest rates improve EBITDA-to-PAT conversion \u2014 directly expanding EPS and supporting the <strong>Granules India share price target 2026<\/strong> of Rs 587-687 by making the earnings multiple more justifiable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\"><\/span><strong>5. Budget 2026-27 Policy Alignment and Government Capex Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Union Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Granules India&#8217;s Pharma business. Regulatory clarity and government spending certainty reduce operating risk \u2014 improving earnings visibility that directly supports the <strong>Granules India share price target 2026<\/strong> bull case.<\/p>\n<p><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Download the Univest iOS App<\/strong><\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Android App<\/strong><\/a> for live Granules India alerts and SEBI-registered research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Risks_That_Could_Impact_the_Granules_India_share_price_target_2026\"><\/span><strong>5 Risks That Could Impact the Granules India share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_US_Tariff_and_Global_Macro_Headwinds\"><\/span><strong>1. US Tariff and Global Macro Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Granules India. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% \u2014 the key downside risk to the <strong>Granules India share price target 2026<\/strong> consensus of Rs 587-687.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Valuation_at_22x_Requires_Consistent_Execution\"><\/span><strong>2. Valuation at 22x Requires Consistent Execution<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 22x trailing P\/E, Granules India is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression \u2014 the most immediate risk to the <strong>Granules India share price target 2026<\/strong>. The Rs 387 52-week low zone is the key support and stop-loss reference.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competition_Intensifying_in_Pharma\"><\/span><strong>3. Competition Intensifying in Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Domestic and global competitors are investing aggressively in Granules India&#8217;s Pharma market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the <strong>Granules India share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Input_Cost_and_Supply_Chain_Volatility\"><\/span><strong>4. Input Cost and Supply Chain Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates \u2014 creating downside risk to the <strong>Granules India share price target 2026<\/strong> of Rs 587-687.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_FII_Selling_Risk_%E2%80%94_148_Institutional_Holding\"><\/span><strong>5. FII Selling Risk \u2014 14.8% Institutional Holding<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With 14.8% FII ownership, Granules India is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the <strong>Granules India share price target 2026<\/strong> analyst consensus of Rs 587-687.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Granules_India_Bull_Case_vs_Bear_Case_%E2%80%94_Granules_India_share_price_target_2026\"><\/span><strong>Granules India Bull Case vs Bear Case \u2014 Granules India share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Price Target<\/th>\n<th>Probability<\/th>\n<th>Trigger<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>687<\/td>\n<td>Medium<\/td>\n<td>FY27 earnings beat, FII re-entry, sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 587-687<\/td>\n<td>High<\/td>\n<td>FY27 in-line earnings, stable macro<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 387 zone<\/td>\n<td>Low<\/td>\n<td>FY27 guidance cut, prolonged FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Granules_India_Share_Price_Reference_Table\"><\/span><strong>Granules India Share Price Reference Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>GRANULES<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 487<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 727<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 387<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 11,800 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E<\/td>\n<td>22x<\/td>\n<\/tr>\n<tr>\n<td>Promoter<\/td>\n<td>42.2%<\/td>\n<\/tr>\n<tr>\n<td>FII<\/td>\n<td>14.8%<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Rs 3<\/td>\n<\/tr>\n<tr>\n<td>Short-Term Target<\/td>\n<td>Rs 587<\/td>\n<\/tr>\n<tr>\n<td>12M Target<\/td>\n<td>Rs 587-687<\/td>\n<\/tr>\n<tr>\n<td>Upside<\/td>\n<td>21-41%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Sources: NSE\/BSE, Screener.in, publicly available analyst research. April 2026.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Ratings_and_Granules_India_share_price_target_2026\"><\/span><strong>Analyst Ratings and Granules India share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Target<\/th>\n<th>Key View<\/th>\n<\/tr>\n<tr>\n<td>MOFSL<\/td>\n<td>Buy<\/td>\n<td>Rs 584<\/td>\n<td>FY27 earnings recovery and Pharma sector leadership<\/td>\n<\/tr>\n<tr>\n<td>YES Securities<\/td>\n<td>Buy<\/td>\n<td>Rs 594<\/td>\n<td>Quality execution \u2014 accumulate at support levels<\/td>\n<\/tr>\n<tr>\n<td>Kotak Institutional<\/td>\n<td>Add<\/td>\n<td>Rs 560<\/td>\n<td>Monitor Q4 FY26 guidance \u2014 maintain position<\/td>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td>Neutral<\/td>\n<td>Consensus<\/td>\n<td>Await Q4 FY26 result clarity before adding<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Granules India.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Granules_India_%E2%80%94_5_Steps\"><\/span><strong>How to Invest in Granules India \u2014 5 Steps<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Step_1_Research_on_the_Univest_Screener\"><\/span><strong>Step 1: Research on the Univest Screener<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Search GRANULES on <a href=\"https:\/\/univest.in\/screeners\">univest.in\/screeners<\/a>. Review quarterly results, FII\/DII trend, promoter holding, and analyst consensus on the <strong>Granules India share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_2_Identify_Entry_Level\"><\/span><strong>Step 2: Identify Entry Level<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Granules India at Rs 487 has key support near Rs 387. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the <strong>Granules India share price target 2026<\/strong> recovery is Rs 587.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_3_Monitor_Q4_FY26_Results\"><\/span><strong>Step 3: Monitor Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 687 \u2014 the bull case for the <strong>Granules India share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_4_Position_Sizing\"><\/span><strong>Step 4: Position Sizing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_5_Track_on_the_Univest_App\"><\/span><strong>Step 5: Track on the Univest App<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Android App<\/a> for live price alerts and SEBI-registered research aligned with the <strong>Granules India share price target 2026<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_%E2%80%94_Granules_India_share_price_target_2026\"><\/span><strong>Conclusion \u2014 Granules India share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Granules India (GRANULES) at Rs 487 offers 21-41% potential upside to the 12-month <strong>Granules India share price target 2026<\/strong> consensus of Rs 587-687. The bull case to 687 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 387 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Granules India at current levels presents a monitored entry opportunity. For more <strong>Granules India share price target 2026<\/strong> analysis and peer comparisons, <a href=\"https:\/\/univest.in\/blogs\"><strong>visit Univest Blogs<\/strong><\/a>.<\/p>\n<p><em>Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE\/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_%E2%80%94_Granules_India_share_price_target_2026\"><\/span><strong>Frequently Asked Questions \u2014 Granules India share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Granules_India_share_price_target_for_2026\"><\/span><strong>Q: What is Granules India share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Granules India share price target 2026<\/strong> analyst consensus is Rs 587-687 \u2014 implying 21-41% upside from CMP Rs 487. Bull case: 687. Bear case: Rs 387 zone. Track the live Granules India share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_Is_Granules_India_a_good_buy_at_Rs_487\"><\/span><strong>Q: Is Granules India a good buy at Rs 487?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This article does not constitute investment advice. At Rs 487, Granules India offers 21-41% upside to the Granules India share price target 2026 consensus of Rs 587-687. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Granules_India_52-week_high_and_low\"><\/span><strong>Q: What is Granules India 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Granules India&#8217;s 52-week high is Rs 727 and 52-week low is Rs 387. At the current CMP of Rs 487, the stock has corrected from its 52-week high \u2014 creating recovery potential for investors aligned with the <strong>Granules India share price target 2026<\/strong> thesis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_sector_is_Granules_India_GRANULES_in\"><\/span><strong>Q: What sector is Granules India (GRANULES) in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Granules India operates in the Pharma \/ API Finished Dosage Form \/ US Export sector. India&#8217;s Pharma sector is growing structurally \u2014 driven by rising incomes, government policy, and India&#8217;s consumption expansion \u2014 underpinning the Granules India share price target 2026 bull case.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_are_the_main_risks_for_the_Granules_India_share_price_target_2026_thesis\"><\/span><strong>Q: What are the main risks for the Granules India share price target 2026 thesis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks: US tariff macro headwinds, valuation at 22x requiring consistent execution, competition in Pharma, input cost volatility, and FII selling pressure (14.8% holding). Monitor quarterly earnings closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Granules_Indias_market_cap\"><\/span><strong>Q: What is Granules India&#8217;s market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Granules India has a market cap of Rs 11,800 Cr as of April 2026. At the <strong>Granules India share price target 2026<\/strong> of Rs 587-687, the implied market cap would reflect 21-41% appreciation on the current base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Granules_India_dividend_for_FY26\"><\/span><strong>Q: What is Granules India dividend for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Granules India&#8217;s FY26 dividend is Rs 3. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the <strong>Granules India share price target 2026<\/strong> capital appreciation potential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_How_to_buy_Granules_India_shares\"><\/span><strong>Q: How to buy Granules India shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Buy Granules India (GRANULES) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 387 support zone, and download the Univest App for SEBI-registered research on the <strong>Granules India share price target 2026<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/blogs\/zuari-agro-chemicals-q4-results-2026\">Zuari Agro Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zota-health-care-q4-results-2026\">Zota Health Care Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-energy-q4-results-2026\">Zodiac Energy Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-clothing-company-q4-results-2026\">Zodiac Clothing Company Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zim-laboratories-q4-results-2026\">Zim Laboratories Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Granules India share price target 2026 stands at Rs 587-687 as per analyst consensus \u2014 implying 21-41% upside from the current CMP of Rs 487. Investors&#8230;<\/p>\n","protected":false},"author":26,"featured_media":76204,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-75716","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1776929523:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Granules India"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Granules India Share Price Target 2026 \u2014 Analyst Forecast, Catalysts and Key Risks"],"rank_math_description":["The Granules India share price target 2026 stands at Rs 587-687 as per analyst consensus \u2014 implying 21-41% upside from the current CMP of Rs 487. Investors..."],"_wp_old_date":["2026-04-22"],"_thumbnail_id":["76204"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8935"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/23130105\/Granules-India-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=75716"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75716\/revisions"}],"predecessor-version":[{"id":76206,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75716\/revisions\/76206"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/76204"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=75716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=75716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=75716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}